Mealey's (April 2, 2019, 1:17 PM EDT) -- WASHINGTON, D.C. — In an April 1 holding, the Federal Circuit U.S. Court of Appeals left intact a Virginia federal judge’s dismissal of a patent infringement action involving a patented method for detecting the enzyme myeloperoxidase (MPO) in the blood (The Cleveland Clinic Foundation, et al. v. True Health Diagnostics LLC, No. 18-1218, Fed. Cir., 2019 U.S. App. LEXIS 9451)....